Chromatin Deregulation in Cancer

Subject Area(s): Human Biology and Disease; Cancer Biology

Edited by Scott Armstrong, Dana-Farber Cancer Institute; Steve Henikoff, Fred Hutchinson Cancer Research Center; Chris Vakoc, Cold Spring Harbor Laboratory

Download a Free Excerpt from Chromatin Deregulation in Cancer:

Preface
Index

© 2017 • 382 pages, illustrated (54 color, 10 B&W), index
Hardcover • ~~$135~~ 94.50
ISBN 978-1-621821-40-3
You save: 30%
You will receive free shipping on this item at checkout.
Free shipping offer applies to direct website purchases by individual U.S. and Canada customers only.

Print Book + eBook Best value!	~~$257.85~~ $108.00
Print Book	~~$135~~ $94.50
eBook	~~$122.85~~ $86.00

Bulk discounts available for your lab or class. Click here to inquire.

eBooks use Adobe Digital Editions software. Click here for more information.

Description
Contents

Description

The human genome is packaged into chromatin, which is composed of numerous proteins that help control gene expression, DNA replication and repair, and genome stability. In recent years, it has become clear that the deregulation of chromatin structure plays an important role in numerous cancers.

Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine examines the chromatin components that are commonly mutated, what is understood about the mechanisms that lead to hematological malignancies and solid tumors, and prospects for the therapeutic modulation of chromatin. The contributors describe how histone proteins, histone-modifying enzymes, chromatin remodelers, transcriptional regulatory complexes, enhancer-associated factors, and signaling proteins are dysregulated in cancer pathogenesis. In addition, the roles of DNA methylation and noncoding RNAs are covered.

The authors also discuss small molecules and other drugs that are currently under development or already used to treat cancer (e.g., HDAC inhibitors and DNA hypomethylating agents). This book is therefore essential reading for all cancer biologists, cell and molecular biologists, and pharmacologists interested in understanding cancer therapies.

Preface
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer: Anne Laugesen, Jonas Westergaard Højfeldt, and Kristian Helin
The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer: Richard L. Bennett, Alok Swaroop, Catalina Troche, and Jonathan D. Licht
Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia: Andrei V. Krivtsov, Takayuki Hoshii, and Scott A. Armstrong
Oncogenic Mechanisms of Histone H3 Mutations: Daniel N. Weinberg, C. David Allis, and Chao Lu
MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer: Christie C. Sze and Ali Shilatifard
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer: Courtney Hodges, Jacob G. Kirkland, and Gerald R. Crabtree
DNMT3A in Leukemia: Lorenzo Brunetti, Michael C. Gundry, and Margaret A. Goodell
TET2 in Normal and Malignant Hematopoiesis: Robert L. Bowman and Ross L. Levine
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer: Narsis Attar and Siavash K. Kurdistani
The Role of Additional Sex Combs-Like Proteins in Cancer: Jean-Baptiste Micol and Omar Abdel-Wahab
SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation: Catherine C. Fahey and Ian J. Davis
ATRX and DAXX: Mechanisms and Mutations: Michael A. Dyer, Zulekha A. Qadeer, David Valle-Garcia, and Emily Bernstein
The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer: Alea A. Mills
Cohesin Mutations in Cancer: Magali De Koninck and Ana Losada
HDACs and HDAC Inhibitors in Cancer Development and Therapy: Yixuan Li and Edward Seto
DNA Hypomethylating Drugs in Cancer Therapy: Takahiro Sato, Jean-Pierre J. Issa, and Patricia Kropf
Targeting Cancer Cells with BET Bromodomain Inhibitors: Yali Xu and Christopher R. Vakoc
Histone Lysine Demethylase Inhibitors: Ashwini Jambhekar, Jamie N. Anastas, and Yang Shi
Mechanisms of Nucleosome Dynamics In Vivo: Steven Henikoff
Nonhistone Lysine Methylation in the Regulation of Cancer Pathways: Scott M. Carlson and Or Gozani
Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology: Adam M. Schmitt and Howard Y. Chang
Index

Chromatin Deregulation in Cancer

Description

Contents